Amylcinnamaldehyde

Amyl cinnamal is useful as a jasmine-floral body note in soap and detergent fragrances because it combines alkaline-system suitability, substantivity contribution, and a more controllable cost than natural jasmine materials. First, it is generally regarded as suitable for conventional alkaline soap perfumery, helping to retain a warm, sweet floral structure through manufacture and storage; performance should nevertheless be verified under the actual process temperature, alkalinity, and storage conditions. Second, its hydrophobic character and reported odour persistence can provide a lasting floral background on fabric, skin, or washed substrates, although actual deposition and substantivity depend on the surfactant system, fragrance carrier, deposition aids, and wash conditions. Third, as a scalable single aroma chemical, it provides a cost-effective and more consistent way to build a jasmine-type floral accord, whereas jasmine absolute is constrained by flower harvesting, low extraction yield, and origin-dependent supply; it is better used to add natural, indolic, or animalic complexity. Amyl cinnamal is IFRA-restricted and associated with skin-sensitisation concerns, so the final use level must be calculated for the finished-product category, complete fragrance formula, and intended market (Api et al., 2015, Food and Chemical Toxicology; IFRA, 2023, 51st Amendment Standards).

Available public evidence supports evaluating amyl cinnamal as an α,β-unsaturated aldehyde building block in research-oriented organic synthesis, not as an established pharmaceutical intermediate or pharmacologically active ingredient. Its conjugated enal structure can participate in transformations that assemble complex heterocyclic frameworks; for example, an amyl-cinnamaldehyde-derived substrate was used in a palladium-catalysed [5+2] annulation to prepare spirobarbiturate–tetrahydrooxepine products (Gao et al., 2020, Organic Letters). This demonstrates synthetic compatibility only and does not establish a therapeutic effect, a defined drug class, or clinical development of the starting material or resulting products. Published antimicrobial screening concerns α-amylcinnamaldehyde oxime against Enterococcus hirae, rather than amyl cinnamal against Staphylococcus aureus, Escherichia coli, or cancer cell lines; those in-vitro findings cannot be interpreted as drug efficacy or clinical potential (Surowiak et al., 2022, Scientific Reports). For pharmaceutical process development, assay, isomeric composition, related substances, residual solvents, and elemental impurities should be controlled against the intended route; ICH Q3A(R2) defines impurity-identification and qualification principles for new drug substances, rather than a universal purity requirement for this intermediate (ICH, 2006, Q3A(R2) Impurities in New Drug Substances).